Home » Stocks » MASS

908 Devices, Inc. (MASS)

Stock Price: $51.65 USD 0.62 (1.21%)
Updated Apr 22, 2021 4:00 PM EDT - Market closed
Market Cap 283.30M
Revenue (ttm) 26.89M
Net Income (ttm) -12.91M
Shares Out 5.49M
EPS (ttm) -2.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 22
Last Price $51.65
Previous Close $51.03
Change ($) 0.62
Change (%) 1.21%
Day's Open 51.18
Day's Range 50.62 - 53.19
Day's Volume 153,012
52-Week Range 38.88 - 79.60

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

BOSTON, April 14, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it w...

1 week ago - GlobeNewsWire

BOSTON--(BUSINESS WIRE)--Experienced HR executive with global tech background joins executive leadership team

1 week ago - Business Wire

BOSTON--(BUSINESS WIRE)--Agency selected the MX908 to work closely with local law enforcement to prevent drug smuggling as opioid crisis rages across the country.

2 weeks ago - Business Wire

908 Devices expects 45% revenue growth this year. About 8% below its IPO price, MASS could be a good bet.

3 weeks ago - Forbes

908 Devices Inc (NASDAQ: MASS) is seen as a high-growth life science tools company that analysts at SVB Leerink expect to “outperform” despite conservative 2021 guidance given by its management due to t...

3 weeks ago - Benzinga

2020 Revenue Increased 50% Over Prior Year 2020 Revenue Increased 50% Over Prior Year

3 weeks ago - GlobeNewsWire

Multi-mission device will support field teams with trace detection point of need analysis Multi-mission device will support field teams with trace detection point of need analysis

3 weeks ago - GlobeNewsWire

Last year was a monster year for the initial public offering market, and 2021 looks like it could provide a repeat performance.

Other stocks mentioned: BOLT, MDWT, NEXI, OCDX
1 month ago - 24/7 Wall Street

BOSTON--(BUSINESS WIRE)--Company adds two directors with financial, pharmaceutical, and consumable business expertise.

Other stocks mentioned: AMRX
1 month ago - Business Wire

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financi...

2 months ago - Business Wire

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate in...

2 months ago - Business Wire

BOSTON--(BUSINESS WIRE)--Bioprocess Veteran Steve Davenport joins company as Vice President of Commercial Sales.

2 months ago - Business Wire

BOSTON--(BUSINESS WIRE)--908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the closing of its upsized initial pu...

4 months ago - Business Wire

908 Devices is a very interesting business with great potential and recent operating momentum. Expectations have risen quite a bit after a big opening day move higher; I still like the long-term potential.

4 months ago - Seeking Alpha

Shares of 908 Devices Inc. more than doubled on their public debut, as the Massachusetts-based biochemical analysis device company's stock opened 127.6% above the upsized initial public offering's price...

4 months ago - Market Watch

Research device maker prices shares at $20 each.

4 months ago - Barrons

BOSTON--(BUSINESS WIRE)--908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the pricing of its upsized initial pu...

4 months ago - Business Wire

908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced that it has filed a registration statement on Form S-1 with the U.S...

4 months ago - Business Wire

908 Devices, which provides a suite of mass spectrometry devices for scientific research, filed on Wednesday with the SEC to raise up to $75 million in an initial public offering.

4 months ago - NASDAQ

908 Devices, Inc. has filed to go public with an IPO on the NASDAQ.

4 months ago - SEC

About MASS

908 Devices has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Leveraging our proprietary platform technology, we make the extraordinary analytical power of Mass Spec available in devices that are significantly smaller and more accessible than conventional laboratory instruments. Our Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical p... [Read more...]

Industry
Medical Devices
IPO Date
Dec 18, 2020
CEO
Kevin J. Knopp
Employees
101
Stock Exchange
NASDAQ
Ticker Symbol
MASS
Full Company Profile

Financial Performance

In 2020, 908 Devices's revenue was $26.89 million, an increase of 49.64% compared to the previous year's $17.97 million. Losses were -$12.82 million, -4.14% less than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for 908 Devices stock is "Strong Buy." The 12-month stock price forecast is 67.50, which is an increase of 30.69% from the latest price.

Price Target
$67.50
(30.69% upside)
Analyst Consensus: Strong Buy